DASATINIB vs DEFLAZACORT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DASATINIB vs DEFLAZACORT: Safety Overview
| Metric | DASATINIB | DEFLAZACORT |
|---|---|---|
| Total FAERS Reports | 30,019 | 3,831 |
| Deaths Reported | 2,681 | 149 |
| Death Rate | 8.9% | 3.9% |
| Hospitalizations | 6,437 | 592 |
| Average Patient Age | 56.4 yrs | 25.7 yrs |
| % Female Patients | 51.9% | 15.1% |
| FDA Approval Date | Apr 22, 2025 | Apr 25, 2024 |
| Manufacturer | Zydus Pharmaceuticals USA Inc. | Cranbury Pharmaceuticals, LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |